Nanjing Immunophage Biomedical Co., Ltd.

Calculating rank

USPTO Granted Patents = 2

EPO Patents = 1

Forward Citations = 0

Loading Chart...

4 inventors (with patents filed for the assignee):

Hongyu Yang (2 out of 4 patents)

Jianfei Wang (2 out of 3 patents)

Guohuang Fan (2 out of 3 patents)

4. Kin Chiu Fong (2 out of 4 patents)

2 patents: Sort by Forward Citations

1. 12692239 - Methods and compositions for targeting Tregs using CCR8 inhibitors (2026-07-28),

2. 12552753 - Methods and compositions for targeting Tregs using CCR8 inhibitors (2026-02-17),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2 Patents

#182 in Nanjing

#11,649 in China

Nanjing, China

Nanjing Immunophage Biomedical Co., Ltd.

Forward Citations = 0

4 inventors:

Hongyu Yang (2 out of 4 patents)

Jianfei Wang (2 out of 3 patents)

Guohuang Fan (2 out of 3 patents)

4. Kin Chiu Fong (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanjing Immunophage Biomedical Co., Ltd.. Retrieved from https://idiyas.com/company/nanjing-immunophage-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]